Alternatives to AN2 Therapeutics
AN2 Therapeutics is a Biotechnology tool: clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to AN2 Therapeutics
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
BiotechnologymRNA TechnologyUpdated 9 Jul 2026- JUJuno TherapeuticsNot rated
Biotechnology company focused on developing cancer immunotherapies.
BiotechnologyPharmaceuticalsUpdated 13 Sept 2026
Jazz Pharmaceuticals3.0 out of 5 (1)Global biopharmaceutical company focused on oncology and neuroscience treatments.
BiotechnologyPharmaceuticalsUpdated 6 May 2026
BioNTechNot ratedGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
BiotechnologyDrug DiscoveryUpdated 7 May 2026
Pixelgen TechnologiesNot ratedA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
BiotechnologyLife SciencesUpdated 24 Aug 2026
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
BiotechnologyPharmaceuticalsUpdated 13 Sept 2026
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
BiotechnologyPharmaceuticalsUpdated 19 Aug 2026
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
BiotechnologyPharmaceuticalsUpdated 8 May 2026
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
BiotechnologyDrug DiscoveryUpdated 1 May 2026
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
BiotechnologyPharmaceuticalsUpdated 5 Aug 2026
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
BiotechnologyPharmaceuticalsUpdated 1 May 2026
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
BiotechnologyPharmaceuticalsUpdated 30 Aug 2026
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
BiotechnologyHealthUpdated 25 Aug 2026- EAEarendil LabsNot rated
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
BiotechnologyArtificial IntelligenceUpdated 23 Aug 2026
CellaresNot ratedThe first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
BiotechnologyPharmaceuticalsUpdated 1 Sept 2026
Ray TherapeuticsNot ratedPioneering vision restoration therapies for severe retinal degenerations.
BiotechnologyPharmaceuticalsUpdated 22 Apr 2026
Immix Biopharma, Inc.Not ratedA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
BiotechnologyPharmaceuticalsUpdated 22 Jul 2026
ONCOMATRYXNot ratedDeveloping Quantum ADCs against the tumor microenvironment for innovative cancer therapies.
BiotechnologyPharmaceuticalsUpdated 12 Apr 2026
Orthogon TherapeuticsNot ratedDeveloping first-in-class oral therapy for BK polyomavirus infections.
BiotechnologyPharmaceuticalsUpdated 18 Apr 2026
Cartography BiosciencesNot ratedA biotechnology company focused on oncology drug discovery.
BiotechnologyOncologyUpdated 28 Sept 2026
Showing the 20 closest matches. See the rest on the AN2 Therapeutics profile.